157 related articles for article (PubMed ID: 33435656)
1. [A Case of Extragonadal Germ Cell Tumor Treated by Induction Therapy with A Reduced Bep Regimen].
Owa S; Sasaki T; Ishihara M; Watanabe S; Kato M; Sugino Y; Kato M; Masui S; Nishikawa K; Yoshio Y; Kanda H; Sugimura Y; Inoue T
Hinyokika Kiyo; 2020 Dec; 66(12):449-452. PubMed ID: 33435656
[TBL] [Abstract][Full Text] [Related]
2. [Modified BEP regimen leads to abatement of choriocarcinoma syndrome in a patient with extra gonadal germ cell tumor : a case report].
Oshima J; Uemura M; Kato T; Nagahara A; Kiuchi H; Tsujimura A; Nonomura N
Hinyokika Kiyo; 2014 Apr; 60(4):183-7. PubMed ID: 24882231
[TBL] [Abstract][Full Text] [Related]
3. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
[TBL] [Abstract][Full Text] [Related]
4. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
5. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution.
Cary C; Jacob JM; Albany C; Masterson TA; Hanna NH; Einhorn LH; Foster RS
Clin Genitourin Cancer; 2018 Apr; 16(2):e307-e313. PubMed ID: 29104087
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
8. Late testicular relapse two decades after primary extragonadal germ cell tumor with uncommon metastases: a case report.
Tobiume M; Aoki S; Nishikawa G; Muramatsu H; Ono K; Morinaga S; Hara K; Ando N; Ono K; Nishibata C; Hidano A; Nakagawa M; Takahashi I; Matsubara K; Yamada Y
J Med Case Rep; 2021 Feb; 15(1):59. PubMed ID: 33541424
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Metachronous Testicular Tumor Developing Twenty Years after Treatment of Retroperitoneal Extragonadal Germ Cell Tumor].
Tobiume M; Yamada Y; Aoki S; Hara K; Muramatsu H; Nishikawa G; Ono K; Takayanagi Y; Nakamura K
Hinyokika Kiyo; 2020 Jun; 66(6):171-176. PubMed ID: 32605355
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
11. Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell Tumors.
Calaway AC; Foster RS; Adra N; Masterson TA; Albany C; Hanna NH; Einhorn LH; Cary C
J Clin Oncol; 2018 Oct; 36(29):2950-2954. PubMed ID: 30156983
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
[TBL] [Abstract][Full Text] [Related]
13. [Case of far-advanced retroperitoneal extra-gonadal germ cell tumor responding to intensive treatment including multi-drug chemotherapy with peripheral blood stem cell transplantation and residual tumor removal].
Yamashita T; Morozumi M; Takagi D; Yoshinaga A; Ishii N; Matsuda T; Terao T; Yamada T
Nihon Hinyokika Gakkai Zasshi; 2010 Mar; 101(3):565-9. PubMed ID: 20387517
[TBL] [Abstract][Full Text] [Related]
14. [Tumor Lysis Syndrome in a Patient with Germ Cell Tumor : A Case Report].
Koterazawa S; Masui K; Hama Y; Takahashi Y; Sawada A; Akamatsu S; Kobayashi T
Hinyokika Kiyo; 2022 Jun; 68(6):201-205. PubMed ID: 35850510
[TBL] [Abstract][Full Text] [Related]
15. Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase.
Kimakura M; Abe T; Nagahara A; Fujita K; Kiuchi H; Uemura M; Nonomura N
Anticancer Drugs; 2016 Apr; 27(4):364-8. PubMed ID: 26736135
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin, etoposide and cisplatinum (BEP) chemotherapy for metastatic germ cell tumours: treatment outcomes at UKM medical centre, Malaysia.
Azrif M; Leong YK; Aslan NM; Fong KV; Ismail F
Asian Pac J Cancer Prev; 2012; 13(6):2467-71. PubMed ID: 22938405
[TBL] [Abstract][Full Text] [Related]
17. [Severe Acute Myocardial Infarction during Induction Chemotherapy for Retroperitoneal Germ Cell Tumor : A Case Report].
Sakka S; Kawai K; Tsujimoto I; Kurobe M; Ichioka D; Kantori S; Kojima T; Suetomi T; Jouraku A; Miyazaki J; Hoshi T; Nishiyama H
Hinyokika Kiyo; 2016 Sep; 62(9):483-487. PubMed ID: 27760974
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
Vidal AD; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
Ann Oncol; 2015 Feb; 26(2):374-7. PubMed ID: 25392157
[TBL] [Abstract][Full Text] [Related]
19. [Two Cases of Germ Cell Tumors with Hyperthyroidism Due to High Serum hCGLevels].
Chihara I; Nitta S; Kimura T; Kandori S; Kawahara T; Waku N; Kojima T; Joraku A; Miyazaki J; Iwasaki H; Suzuki H; Kawai K; Nishiyama H
Hinyokika Kiyo; 2016 Sep; 62(9):489-493. PubMed ID: 27760975
[TBL] [Abstract][Full Text] [Related]
20. Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
Culine S; Théodore C; Bekradda M; Farhat F; Terrier-Lacombe MJ; Droz JP
Am J Clin Oncol; 1997 Apr; 20(2):184-8. PubMed ID: 9124197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
